Agilent Technologies, Inc. - Diagnostics and Genomics ClearSeq Inherited Disease, 12, XT2
The Agilent ClearSeq Inherited Disease, 12 reactions, XT2 (part number 5190-7525) is a targeted next-generation sequencing (NGS) panel designed for the detection of inherited disease-associated variants. Developed using SureSelect technology, this panel enables comprehensive analysis of genes linked to a wide range of inherited disorders. The kit provides reagents for 12 reactions and is optimized for high sensitivity and specificity, supporting efficient library preparation and target enrichment. It is intended for use in research applications to facilitate the identification of genetic variants in inherited disease studies.